alpha-Gal oligosaccharides: Chemistry and potential biomedical application

Citation
A. Janczuk et al., alpha-Gal oligosaccharides: Chemistry and potential biomedical application, CURR MED CH, 6(2), 1999, pp. 155-164
Citations number
69
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CURRENT MEDICINAL CHEMISTRY
ISSN journal
09298673 → ACNP
Volume
6
Issue
2
Year of publication
1999
Pages
155 - 164
Database
ISI
SICI code
0929-8673(199902)6:2<155:AOCAPB>2.0.ZU;2-#
Abstract
This article focuses on the most recent research efforts by the Wang group in the field of alpha-Gal oligosaccharides. alpha-Gal oligosaccharides are carbohydrate structures bearing a Gal alpha 1-3Gal beta terminus. This clas s of compounds are believed to act as xenoactive antigens that instigate th e hyperacute rejection in xenotransplantation. Enzymatic methods using reco mbinant alpha 1-3 galactosyltransferase were employed to synthesize several alpha- Gal oligosaccharides. In addition, a chemical synthetic scheme was devised in order to produce readily acessible amounts of alpha-Gal. Conform ational analysis was done using both NMR techniques and molecular modeling protocols. These studies provide important information in the structure-fun ction relationship of alpha-Gal and anti-alpha-Gal antibodies. The second part of this article deals with the use of alpha-Gal in immunoth erapy. Based on the abundance of anti-alpha-Gal antibodies IgM and IgG in h uman blood serum, alpha-Gal conjugates may act as effective immunotheraputi c drugs. Recent studies have discovered characteristic peptide sequences co ntaining Arg-Gly-Asp (RGD) motif that binds to integrins on the surface of cancer cells. A alpha-Gal conjugate was developed by chemical coupling a al pha-Gal trisaccharide to a RGD peptide. Preliminary studies using the conju gate on prostate DU-145 cancer cells showed a reduction in the survival rat e of the cells.